Cigarette Smokers are Less Likely to Have Undetectable Viral Loads: Results From Four HIV Clinics

被引:31
作者
Cropsey, Karen L. [1 ]
Willig, James H. [1 ]
Mugavero, Michael J. [1 ]
Crane, Heidi M. [2 ]
McCullumsmith, Cheryl [1 ]
Lawrence, Sarah [1 ]
Raper, James L. [1 ]
Mathews, W. Christopher [3 ]
Boswell, Stephen [4 ]
Kitahata, Mari M. [2 ]
Schumacher, Joseph E. [1 ]
Saag, Michael S. [1 ]
机构
[1] Univ Alabama Birmingham, Birmingham, AL 35294 USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Univ Calif San Diego, San Diego, CA 92103 USA
[4] Fenway Community Hlth Ctr, Boston, MA USA
关键词
smoking; HIV; comorbidities; ACTIVE ANTIRETROVIRAL THERAPY; SCREENING-TEST ASSIST; SMOKING-CESSATION; POSITIVE SMOKERS; UNITED-STATES; OPEN-LABEL; HEALTH; HIV/AIDS; ALCOHOL; DISEASE;
D O I
10.1097/ADM.0000000000000172
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: The prevalence of smoking among HIV-infected individuals is 2-3 times that of the general population, increasing the risk of smoking-related morbidity and mortality. We examined characteristics associated with smoking behavior among a large cohort of HIV-infected individuals in care in the United States. Methods: A convenience sample of 2952 HIV-infected patients in the Centers for AIDS Research (CFAR) Network of Integrated Clinical Systems (CNICS) was assessed during routine clinic visits and was included. Multinomial logistic regression was used to examine the relationship between smoking status, depression/panic symptoms, alcohol/substance use, and demographic and clinical characteristics. Results: Compared with never-smokers, current smokers were more likely to have moderate to severe depression (odds ratio [OR] 1.37), endorse current substance use (OR 14.09), and less likely to report low-risk alcohol use on the Alcohol Use Disorders Identification Test (AUDIT-C) (OR 0.73). Current smokers were less likely to have an undetectable viral load (OR 0.75), and more likely to have current substance abuse (OR 2.81) and moderate to severe depression (OR 1.50), relative to smokers who had quit smoking. Conclusions: HIV-infected smokers are less likely to have undetectable viral loads and frequently have psychosocial comorbidities including depression and substance abuse that impact antiretroviral therapy adherence and viral load suppression. To be effective, smoking-cessation interventions need to address the complex underlying concurrent risks in this population.
引用
收藏
页码:13 / 19
页数:7
相关论文
共 49 条
  • [1] Ali R, 2002, ADDICTION, V97, P1183
  • [2] HIV Status, Burden of Comorbid Disease, and Biomarkers of Inflammation, Altered Coagulation, and Monocyte Activation
    Armah, Kaku A.
    McGinnis, Kathleen
    Baker, Jason
    Gibert, Cynthia
    Butt, Adeel A.
    Bryant, Kendall J.
    Goetz, Matthew
    Tracy, Russell
    Oursler, Krisann K.
    Rimland, David
    Crothers, Kristina
    Rodriguez-Barradas, Maria
    Crystal, Steve
    Gordon, Adam
    Kraemer, Kevin
    Brown, Sheldon
    Gerschenson, Mariana
    Leaf, David A.
    Deeks, Steven G.
    Rinaldo, Charles
    Kuller, Lewis H.
    Justice, Amy
    Freiberg, Matthew
    [J]. CLINICAL INFECTIOUS DISEASES, 2012, 55 (01) : 126 - 136
  • [3] An open-label, prospective, observational study of the incidence of coronary artery disease in patients with HIV infection receiving highly active antiretroviral therapy
    Barbaro, G
    Di Lorenzo, G
    Cirelli, A
    Grisorio, B
    Lucchini, A
    Hazra, C
    Barbarini, G
    [J]. CLINICAL THERAPEUTICS, 2003, 25 (09) : 2405 - 2418
  • [4] Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States
    Bing, EG
    Burnam, A
    Longshore, D
    Fleishman, JA
    Sherbourne, CD
    London, AS
    Turner, BJ
    Eggan, F
    Beckman, R
    Vitiello, B
    Morton, SC
    Orlando, M
    Bozzette, SA
    Ortiz-Barron, L
    Shapiro, M
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (08) : 721 - 728
  • [5] Bradley KA, 1998, ALCOHOL CLIN EXP RES, V22, P1842, DOI 10.1097/00000374-199811000-00034
  • [6] Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG Adherence Instruments
    Chesney, MA
    Ickovics, JR
    Chambers, DB
    Gifford, AL
    Neidig, J
    Zwickl, B
    Wu, AW
    [J]. AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2000, 12 (03): : 255 - 266
  • [7] Routine collection of patient-reported outcomes in an HIV clinic setting: The first 100 patients
    Crane, Heidi M.
    Lober, William
    Webster, Eric
    Harrington, Robert D.
    Crane, Paul K.
    Davis, Thomas E.
    Kitahata, Mari M.
    [J]. CURRENT HIV RESEARCH, 2007, 5 (01) : 109 - 118
  • [8] The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans
    Crothers, K
    Griffith, TA
    McGinnis, KA
    Rodriguez-Barradas, MC
    Leaf, DA
    Weissman, S
    Gibert, CL
    Butt, AA
    Justice, AC
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2005, 20 (12) : 1142 - 1145
  • [9] Safety and Tolerability of Varenicline Tartrate (Champix®/Chantix®) for Smoking Cessation in HIV-Infected Subjects: A Pilot Open-Label Study
    Cui, Qu
    Robinson, Linda
    Elston, Dawn
    Smaill, Fiona
    Cohen, Jeffrey
    Quan, Corinna
    McFarland, Nancy
    Thabane, Lehana
    McIvor, Andrew
    Zeidler, Johannes
    Smieja, Marek
    [J]. AIDS PATIENT CARE AND STDS, 2012, 26 (01) : 12 - 19
  • [10] Cummins Denise, 2005, Nurs Stand, V20, P41